Swedish Biotech Nordberg Medical Hosts Japan Launch Reception
The reception marks Nordberg Medical's formal entry into Japan's aesthetic medicine market, with an emphasis on academic exchange and transferring biomaterial science from Sweden to local medical professionals.
Reporting from 1 source: ASCII.jp.
Nordberg Medical, a Swedish biotech company developing medical biomaterials for aesthetic medicine, held a launch reception in Tokyo on June 26, 2026, to celebrate the opening of its Japan subsidiary. Around 120 people attended, roughly 70% of them doctors in plastic surgery, cosmetic surgery, and cosmetic dermatology. CEO Yuki Sakurai outlined the company's plans for educational and academic activities in the Japanese market.
Nordberg Medical formally established its Japan subsidiary on May 18, 2026, about six weeks before the June 26 launch reception at Happoen Hakuhokan in Tokyo. The event drew roughly 120 participants, the majority of whom were doctors. Lars Hammarstrom, Counselor for Science and Innovation at the Embassy of Sweden in Tokyo, attended as a guest. Company executives included CEO Yuki Sakurai, COO Garth Reynolds, Chairman Wang Jinyue, and Japan COO Hisanori Maei. Sakurai presented the company's activity policy and future educational initiatives for medical professionals. Nordberg Medical, founded in 2017 in Stockholm, researches and manufactures biomaterials for regenerative medicine, with facilities in Uppsala and Malmö.
Synthesized by Yomimono from the 1 cited source below, including Japanese-language reporting where cited, then editorially reviewed before publishing.